Merck-Eisai's Endometrial Cancer Therapy Combo Fails First-Line Treatment Trial

Endometrial Cancer Therapy Combo Fails 1L Treatment Trial Merck said on Friday a combination therapy being developed with partner Eisai failed a late-stage trial testing it as a first-line treatment for a type of cancer in the uterus lining. https://www.medscape.com/s/viewarticle/999144 Merck's Lung Cancer Drug Combo Fails Trial in Setback for New Therapy Class December 08, 2023 https://www.medscape.com/s/viewarticle/999113